Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
20,54%
5-year Growth Rate
R
5/6
5-year Risk Analysis
O
-7,20%
Outlook 12/26
W
59,93%
Margin of safety
T
5,69%
Analyst Price Target
H
DOWN
50-week EMA Trend
Company Info
EPS Growth 5Y
20,65%
Revenue growth 5Y
20,44%
Price growth 5Y
15,49%
Market Cap
kr1.258,27 B
Long-Term Debt
kr110,37 B
Quarterly earnings
08/05/2026
Dividend
kr11,69
Dividend Yield
4,12%
Industry
Country
Website
ISIN Number
Novo Nordisk A/S Price Chart (DKK)
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
kr300,00
5.69%
Last Update: 06/04/2026
Analysts: 23
Highest Price Target kr454,00
Average Price Target kr300,00
Lowest Price Target kr200,00
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Novo Nordisk A/S
CPSE:NOVO B
|
33,36% | 15,49% | 17,87% | 20,54% | 5/6 | -7,20% | 59,93% | 5,69% | DOWN |
